Mfd. by :- Hetero (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand name - Bortero
Generic name - Bortezomib Injection IP
Alternative Brand: Bortecine
Manufacturer - Hetero Drugs Ltd
Salt composition - Bortezomib
Storage - Store at room temperature (10-30°C)
Dosage form - Injection
Strength - 2mg,2.5mg,3.5mg
Packaging - Vial (1 injection in 1 packet)
Active ingredient - Bortezomib
Physical form - Liquid
Suitable for - Adults
Bortero is an anti-cancer medicine. Bortero injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. The active ingredient in Bortero is Bortezomib. Bortezomib is a dipeptide boronic acid derivative and proteasome inhibitor. It is used in the treatment of multiple myeloma and mantle cell lymphoma. It is a reversible inhibitor of the 26S proteasome.
Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in mammalian cells. The 26S proteasome is a large protein complex that degrades ubiquitinated proteins. The active site of the proteasome has chymotrypsin-like, trypsin-like, and post glutamyl peptide hydrolysis activity. The 26S proteasome degrades various proteins critical to cancer cell survival, such as cyclins, tumor suppressors, BCL-2, and cyclin-dependent kinase inhibitors. Inhibition of these degradations sensitizes cells to apoptosis. Bortezomib is a potent inhibitor of 26S proteasome, which sensitizes activity in dividing multiple myeloma and leukemic cells, thus inducing apoptosis. In addition, bortezomib appears to increase the sensitivity of cancer cells to traditional anticancer agents (e.g., gemcitabine, cisplatin, paclitaxel, irinotecan, and radiation).
Bortezomib targets the ubiquitin-proteasome pathway, a molecular pathway that promotes protein degradation and maintains the homeostatic intracellular concentrations of proteins. However, there is strong evidence that the ubiquitin-proteasome pathway is often dysregulated, which leads to aberrant pathway signaling. In one study, patient-derived chronic lymphocytic leukemia (CLL) cells contained 3-fold higher levels of chymotrypsin-like proteasome activity than normal lymphocytes, which indicated that dysregulation of the ubiquitin-proteasome pathway is implicated in malignant cell transformation. Bortezomib prevents the proteasome-mediated proteolysis by reversibly inhibiting an enzyme involved in the ubiquitin-proteasome pathway. Bortezomib exerts a cytotoxic effect on various cancer cell types in vitro. In non-clinical tumour models, including multiple myeloma, bortezomib caused a delay in tumor growth.
Bortero Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It blocks or slows the breakdown of proteins in cells. As a result, the increase in a number of proteins in the cancer cells leads to their death.
Your healthcare provider will give you this medicine. He/She will decide what dose is necessary. Please do not self administer. Take it exactly as your healthcare provider directs.
Myezom 2mmg injection
Bortecad 2mg injection
Biocure 2mg injection
Proteoz 2mg injection
Bortemap 2mg injection
Zomibet 2mg injection
Fatigue
Anemia (low number of red blood cells)
Nausea
Vomiting
Fever
Dizziness
Diarrhea
Constipation
Decreased appetite
Low blood platelets
Peripheral neuropathy (tingling and numbness of feet and hand)
Psychiatric disturbances
Neutrophils (decrease in white blood cell count)
Your healthcare provider will decide what dose is necessary for you, as per your existing/previous medications. If you miss a dose, please contact your healthcare provider.
1. Consult your doctor before taking this medicine if you:
have any liver, kidney, heart disease or bleeding problem;
develop symptoms like memory loss or trouble in thinking.
2. Other medicines can affect/be affected by, this medicine so tell your healthcare provider about the medicines you take.
3. Bortero Injection is not recommended during pregnancy and while breastfeeding.
4. This medicine may cause dizziness, therefore it is recommended to avoid driving or operating machinery.
5. It may reduce the number of blood cells in your blood. Regular blood tests are recommended to keep a track of the same.
1. Consult your doctor before taking this medicine if you:
have any liver, kidney, heart disease or bleeding problem;
develop symptoms like memory loss or trouble in thinking.
2. Other medicines can affect/be affected by, this medicine so tell your healthcare provider about the medicines you take.
3. Bortero Injection is not recommended during pregnancy and while breastfeeding.
4. This medicine may cause dizziness, therefore it is recommended to avoid driving or operating machinery.
5. It may reduce the number of blood cells in your blood. Regular blood tests are recommended to keep a track of the same.
Ques- 1 What is Bortero?
Ans- 1 Bortero Injection is used in the treatment of multiple myeloma.
Ques- 2 How should I take Bortero?
Ans- 2 Your healthcare provider will give you the medicine. Do not self administer.
Ques- 3 What are the possible side effects of Bortero injection?
Ans- 3 Side effects of Bortero injection are low blood platelets, fatigue, dizziness, fever, constipation, diarrhea, decrease in appetite, decrease in white blood cell count, nausea, vomiting and anemia.
Ques- 4 In what strength is Bontero injection available?
Ans- 4 Bontero injection is available in the strength of 2mg.
Ques- 5 What happens if I miss a dose?
Ans- 5 If you miss a dose, please contact your healthcare provider.
Ques- 6 What should I avoid while consuming this medicine?
Ans- 6 Avoid driving while consuming this medicine because it may lead to dizziness.
Ques- 7 What are self care tips?
Ans- 7 Regular blood tests are required because this medicine may reduce the number of blood cells in your blood.
Ques- 8 Can I take this medicine during pregnancy?
Ans- 8 This medicine is not recommended during pregnancy or while breastfeeding.
Ques- 9 Can I drive after taking this medicine?
Ans- 9 You should not drive as it may cause dizziness.
Ques- 10 What are the storage conditions?
Ans- 10 Store at room temperature (10-30°C)
Ques- 11 Is Bortero a habit forming medicine?
Ans- 11 No, it is not a habit forming medicine.
Ques- 12 Is Bortero injection dialyzable?
Ans- 12 Yes, Bortero injection is dialyzable.
Ques- 13 Is Bortero injection FDA approved?
Ans- 13 Yes, Bortero injection is approved by FDA.
Ques- 14 Is Bortero a chemotherapy/hormonal drug/cytotoxic?
Ans- 14 Bortero injection is a chemotherapy/cytotoxic drug, which is used in the treatment of cancers including multiple myeloma and mantle cell lymphoma.
Ques- 15 Does Bortero injection cause constipation?
Ans- 15 Bortero injection may cause side effects like depression.
Ques- 16 Can I stop using this product immediately?
Ans- 16 Some medicines can not be stopped immediately. Please consult your healthcare provider for the same.
Fill the Form
Talk to Executive
Get Tracking
Get Medicines Delivered
